FDA.reportPublic FDA data

ADAMTS13, recombinant-krhn 500 UNT Injection [Adzynma]

RxCUI
2670313
RxNorm name
ADAMTS13, recombinant-krhn 500 UNT Injection [Adzynma]
Display name
ADAMTS13, recombinant-krhn 500 UNT Injection [Adzynma]
Full name
ADAMTS13, recombinant-krhn 500 UNT Injection [Adzynma]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125795ADZYNMAADAMTS13, recombinant-krhn351(a)Rx2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
22728e96-efa0-46c1-bdd1-ad89a796d5e3ADAMTS13, recombinant-krhn 500 UNT Injection [Adzynma]SBD6These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 202320240830
22728e96-efa0-46c1-bdd1-ad89a796d5e3ADZYNMA 500 UNT InjectionPSN6These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 202320240830
22728e96-efa0-46c1-bdd1-ad89a796d5e3Adzynma 500 UNT InjectionSY6These highlights do not include all the information needed to use ADZYNMA safely and effectively. See full prescribing information for ADZYNMA. ADZYNMA (ADAMTS13, recombinant-krhn) lyophilized powder for Injection, for intravenous use Initial U.S. Approval: 202320240830